Search results

Records found: 1  
Your query: Author Sysno/Doc.kind = "^sllk_un_auth 0041090 xcla^"

  1. 1.Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior nonsteroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET).

    Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior nonsteroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET).  / Jerusalem, G. ... [et al.] .  Onkológia. - ISSN 1336-8176 . - Roč. 11, č. 4 (2016), s. 250-251  
    C 3069
    article

    article



  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all